Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.
Dana Pe'er is a Professor and Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute (SKI) of Memorial Sloan Kettering Cancer Center. She is also an Investigator of the Howard Hughes Medical Institute and holds the Alan and Sandra Gerry Endowed Chair. Dr. Pe'er leads an interdisciplinary research group that combines advanced genomics approaches with machine learning to address fundamental questions in biomedical science, with particular focus on cancer biology, developmental biology, and immunology. Dr. Pe'er earned her PhD from Hebrew University in Jerusalem, Israel. Her academic journey includes a postdoctoral fellowship with George Church at Harvard Medical School. Before joining Memorial Sloan Kettering Cancer Center in 2016, she held faculty positions at Columbia University. Dr. Pe'er's research focuses on understanding cellular plasticity, the consequences of intra-tumor heterogeneity, cancer evolution and metastasis, and the mechanisms by which regulatory circuits go awry in disease. Her lab combines single-cell and spatial profiling technologies with machine learning approaches to investigate gene regulation, cellular plasticity, and cell-cell communication in the contexts of cancer, immunity, and development. They are particularly interested in how organisms develop from a single cell to generate diverse cell types, how epigenetic control rewires during development, and how cells communicate to execute multicellular responses. Analysis of Dr. Pe'er's recent publications reveals a strong focus on developing computational methods for single-cell and spatial genomics data analysis. Her work spans cancer types including pancreatic, prostate, colorectal, and breast cancer, with emphasis on tumor heterogeneity, metastasis mechanisms, and cellular plasticity. A significant portion of her research involves creating novel algorithms and tools like CellRank, REUNION, and SEACells that enable researchers to extract meaningful biological insights from complex genomic datasets. 2023 Class of 2023 Inductee - American Academy of Cancer Research (AACR) Academy 2023 Innovator Award - International Society for Computational Biology (ISCB) 2021 Fellow - International Society for Computational Biology (ISCB) Howard Hughes Medical Institute Investigator (2021) 2019 Ernst W. Bertner Memorial Award - University of Texas MD Anderson Cancer Center 2016 Lenfest Distinguished Faculty Award - Columbia University 2014 Director's Pioneer Award - National Institutes of Health 2014 Overton Prize - International Society for Computational Biology (ISCB) Dr. Pe'er is known for her dedicated mentorship approach, describing herself as "a mama bear" who cares deeply about her trainees while expecting independence, innovation, and hard work. She mentors numerous PhD students and postdocs in her lab. Her HHMI Investigator award provides approximately $9 million over seven years, enabling ambitious research directions. She also collaborates extensively with the Single-cell Analytics and Innovation Lab (SAIL) at MSK to generate new data from emerging technologies, working closely with wet-lab collaborators at MSK and beyond to apply computational methods to cutting-edge datasets across multiple disease areas. The Pe'er Lab is an interdisciplinary group of computational biologists with diverse backgrounds ranging from pure mathematics to clinical medicine. They work closely with wet-lab collaborators to apply their computational methods to cutting-edge datasets across cancer, immunology, and developmental biology. The lab is described as open, supportive, collaborative, and fun, with access to world-class facilities at the Sloan Kettering Institute. Dr. Pe'er's work continues to push the boundaries of computational biology and cancer research, with the ultimate goal of developing more effective, personalized therapies for cancer patients.
Daniel J. Field is Professor of Vertebrate Palaeontology in the Department of Earth Sciences and the Strickland Curator of Ornithology at the University of Cambridge Museum of Zoology. He is a Fellow of Christ's College, Cambridge, where Charles Darwin studied as an undergraduate, and serves as the founding director of the Darwin-Hamied Centre at Christ's College. Field also maintains research associate positions at the Denver Museum of Nature and Science and the Natural History Museum (London). Field is an evolutionary biologist and palaeontologist whose research focuses on deciphering the origins of modern avian biodiversity using fossil, anatomical, and molecular data. His work spans multiple themes including clarifying how birds survived and diversified following the mass extinction of non-avian dinosaurs, studying the evolutionary histories of major living bird groups, and understanding the evolutionary origins of distinctive biological features such as the modern bird skull. In 2020, his team announced the discovery of Asteriornis maastrichtensis (the 'Wonderchicken'), the oldest-known modern bird fossil and an early relative of the group that gave rise to living chickens and ducks. Field's publication record shows consistent research output across multiple areas of avian evolution, with recent work focusing on avian palate evolution, skeletal pneumaticity, developmental patterns in bird skulls, and the evolutionary relationships among major bird groups. His research integrates cutting-edge techniques including CT scanning, geometric morphometrics, and phylogenetic analysis to address fundamental questions about vertebrate evolution. Field leads an active research group comprising postdoctoral researchers, PhD students, and master's students from around the world. His lab has produced significant work on topics including the evolution of flightlessness in ratites, the developmental underpinnings of avian morphological diversity, and the phylogenetic relationships among major bird lineages. The lab maintains strong international collaborations and has been instrumental in training the next generation of evolutionary biologists and palaeontologists. Field is passionate about natural history and science outreach, and enjoys photographing Earth's vertebrate biodiversity in the field. His work bridges the gap between traditional palaeontology and modern evolutionary biology, contributing significantly to our understanding of how modern bird diversity arose from their dinosaurian ancestors.
Gary M. Shaw is the Rosemarie Hess Professor and Professor (Research) at Stanford University , with courtesy appointments in the Department of Epidemiology and Population Health and Department of Obstetrics & Gynecology - Maternal Fetal Medicine . He serves as Co-PI of the March of Dimes Prematurity Research Center at Stanford and PI of the California Center for Finding Causes and Preventives of Birth Defects . His research focuses on the Epidemiology of birth defects Gene-environment interactions in perinatal outcomes Nutritional factors in reproductive health . He has developed machine learning approaches for precision parenteral nutrition and predictive models for preterm birth, while investigating persistent metabolomic signatures following hypertensive pregnancy disorders. Shaw's recent work explores Climate change impacts on reproductive health Maternal-fetal immune interactions Epigenetic mechanisms in perinatal disease with applications of multiomics to neonatal intensive care units. As a member of Bio-X and the Maternal & Child Health Research Institute , he contributes to translational research networks while serving as Associate Editor for Birth Defects Research and American Journal of Medical Genetics . He supervises Med Scholar Project student Richard Liang Doctoral co-advisor for Saskia Comess and Richard Liang Master's advisor for Lenae Joe while leading the Division of Neonatology as Associate Chair for Clinical Research (2012-2025). His laboratory work integrates Metabolomic profiling Proteomic analysis Computational modeling Machine learning for biomedical data to advance neonatal care through precision medicine approaches.
Albert M. Berghuis is a Professor in the Department of Biochemistry at McGill University's Faculty of Medicine. His research focuses on structural mechanisms of antibiotic resistance and fungal pathogenesis using advanced techniques including X-ray crystallography, electron microscopy, and computational chemistry. His primary research interests include: Structural basis of antibiotic resistance mechanisms, particularly against aminoglycosides Development of novel antimicrobials through structure-based drug design Structural studies of fungal-specific metabolic pathways for antifungal drug discovery Enzyme mechanisms involving protein-small molecule interactions Analysis of his recent publications reveals a consistent focus on structural elucidation of resistance mechanisms, with particular emphasis on aminoglycoside-modifying enzymes and fungal targets. His work bridges structural biology with therapeutic development, showing strong translational potential in combating antimicrobial resistance. Professor Berghuis maintains the Berghuis Lab with facilities in both the McIntyre Medical Sciences Building and the Francesco Bellini Life Sciences Building. His laboratory employs integrated structural biology approaches to tackle pressing problems in infectious disease treatment.
Xiaoxiao Zhou is an Assistant Professor in the Department of Biostatistics at the University of Alabama at Birmingham (UAB), affiliated with multiple centers including the Center for Outcomes and Effectiveness Research and Education (COERE), Center for Clinical and Translational Science (CCTS), and the Global Center for Craniofacial, Oral and Dental Disorders (GC-CODED). She holds a PhD in Statistics from The Chinese University of Hong Kong (2022) and completed a postdoctoral fellowship at Duke University's Department of Statistical Science. Her research focuses on causal inference, Bayesian methods, longitudinal data analysis, and survival analysis, with applications in Alzheimer’s disease, cardiovascular conditions, and neurodegenerative disorders. Dr. Zhou’s work integrates advanced statistical techniques with medical and behavioral data, including neuroimaging and latent variable modeling. Key areas include handling intercurrent events in clinical trials, causal mediation analysis, and joint modeling of longitudinal and survival outcomes. She collaborates widely with clinicians and biostatisticians to address real-world challenges in healthcare and disease progression studies. Her scholarly contributions span over a dozen peer-reviewed articles, emphasizing methodological innovations in biostatistics and their practical applications. She advises students such as Zhenying Ding and actively participates in academic committees. Outside academia, she enjoys outdoor activities like mountain hiking and weight lifting.
Amjad Javed is a Professor and Associate Dean at the University of Alabama at Birmingham , with primary appointments in the School of Dentistry - Oral & Maxillofacial Surgery and joint affiliations in Cell, Developmental and Integrative Biology , Otolaryngology , and Biomedical Engineering . His research spans bone biology, cartilage development, and myeloma bone disease. PhD in Physiology (University of the Punjab, 2003) MS in Zoology/Animal Biology (University of the Punjab, 1992) Research Interests focus on transcriptional regulation via RUNX2 and Sp7 in skeletogenesis, vascular calcification mechanisms, epigenetic control of bone formation, and tumor-bone microenvironment interactions in multiple myeloma. Key subfields include endochondral ossification, osteoclast differentiation, and nanomatrix-based tissue engineering. Scientific Contributions include discoveries about RUNX2's role in postnatal bone resorption, λ5 protein's impact on skeletal aging, and heparanase's promotion of myeloma metastasis. His work demonstrates RUNX2's dual function in chondrocyte apoptosis and cartilage degradation. Teaching & Mentorship involves graduate committee service for over 15 students and instruction in courses like Connective Tissue and Bone , Oral & Skeletal Biology , and Journal Clubs . Collaborations span Comprehensive Arthritis, Musculoskeletal, Bone and Autoimmunity Center , Integrative Center for Aging Research , and Biomatrix Eng Regen Med Center .
Guillermo A. Ameer serves as the Daniel Hale Williams Professor of Biomedical Engineering at Northwestern University's McCormick School of Engineering and Professor of Surgery in the Feinberg School of Medicine. He directs the Center for Advanced Regenerative Engineering (CARE) and maintains affiliations with the Simpson-Querrey Institute, Chemistry of Life Processes Institute, and the IBiS Graduate Program. His leadership extends to founding the Regenerative Engineering Laboratory, which pioneered citrate-based antioxidant biomaterials known as polydiolcitrates. Americas' leading innovator in regenerative engineering, Ameer's research spans vascular, orthopaedic, and bladder tissue engineering. His lab developed Nanonets™ thermoresponsive oligomers and photoresponsive liquid polymers for applications including wound healing, islet transplantation, and 3D-printed vascular scaffolds. Notable breakthroughs include bioresorbable stents, bladder regeneration scaffolds, and diabetic wound healing technologies that have received FDA clearance and commercial implementation through companies like Acuitive Technologies and VesselTek BioMedical. His publication record demonstrates consistent innovation in biomaterials science, with research trends showing progression from fundamental polymer chemistry to sophisticated clinical applications. Recent work focuses on electroactive bladder scaffolds, 3D-printed vascular devices, and wearable health monitoring systems, reflecting his commitment to translating laboratory discoveries into tangible medical solutions. The 2025 launch of the Regenerative Engineering Institute underscores his growing institutional impact. Percy L. Julian Award (2024) BMES Athanasiou Medal of Excellence in Translational Bioengineering (2023) Election to National Academy of Medicine (2021) National Academy of Inventors Fellow (2019) AAAS Fellow (2018) AIChE Fellow (2017) Ameer has mentored over 30 PhD and Master's students who now lead research at institutions including Penn State, USC, and the FDA. His lab secures substantial NIH funding, including an American Recovery and Reinvestment Act Challenge Grant for liquid cast arterial stents. Current projects include the development of citrate-based biomaterials for bladder regeneration, diabetic wound healing, and bioresorbable vascular scaffolds, with multiple technologies transitioning to clinical applications through partnerships with medical device companies. The Regenerative Engineering Laboratory maintains a collaborative interdisciplinary environment with approximately 20 researchers spanning engineering and natural sciences disciplines. Recent initiatives include the development of wearable skin gas sensors (2025) and CITREPORE™ bone void filler (2024), demonstrating the lab's capacity to address diverse clinical challenges through biomaterials innovation.
Craig B. Birgfeld, M.D. , is a professor in the Department of Surgery at the University of Washington School of Medicine and serves as Director of the UW Fellowship in Craniofacial Surgery. He practices at the Burn and Plastic Surgery Clinics at Harborview Medical Center, specializing in congenital craniofacial abnormalities, trauma reconstruction, and pediatric plastic surgery. Educational Background: Virginia Commonwealth University School of Medicine (Medical Education, 2000) University of Washington - Fellowship in Craniofacial Surgery Hospital of the University of Pennsylvania - Residency in Plastic Surgery Hospital of the University of Pennsylvania - Internship in General Surgery Dr. Birgfeld's research focuses on Craniofacial Microsomia and outcomes analysis in surgical interventions for congenital skull and facial abnormalities. His clinical work emphasizes trauma reconstruction, cleft lip/palate surgery, and craniofacial plastic surgery. He actively teaches Plastic Surgery residents and Craniofacial fellows, aiming to cultivate top-tier surgeons in the field. Recent publications highlight advancements in craniosynostosis treatment, facial symmetry measurement, and outcomes in craniofacial surgical procedures. His work spans collaborations with multidisciplinary teams in neurosurgery, pediatrics, and genetic research.
Dr. Chang Lei is an ARC Discovery Early Career Researcher Award (DECRA) Fellow at the Department of Medical Sciences within the Faculty of Medicine and Health at The University of Sydney. She is also a member of The University of Sydney Nano Institute and the Charles Perkins Centre. With expertise in nanotechnology-based bioanalysis, mass spectrometry, lateral flow immunoassay, and tissue regeneration, Dr. Lei leads several innovative research projects focused on advancing healthcare through nanotechnology. Dr. Lei completed her PhD at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at The University of Queensland (UQ). Her academic journey includes receiving the Queensland Government Advance Queensland Research Fellowship, the UQ Amplify Fellowship in 2021, and the prestigious ARC DECRA in 2024. Her research interests span across nanotechnology applications in healthcare, with particular focus on: Developing novel nanomaterials for single-cell metabolomics analysis Creating affordable and ultra-sensitive biomarker detection platforms Engineering silica bio-nanomaterials for stem cell differentiation and bone repair Advancing lateral flow immunoassay technologies using nanomaterials Applying nanotechnology to dental and craniofacial regeneration Dr. Lei's publication record demonstrates a strong focus on nanotechnology applications across multiple disciplines. Her recent work shows increasing emphasis on medical applications of nanomaterials, particularly in diagnostics, cancer therapy, and tissue regeneration. She has published in high-impact journals including Nature Science Review, Small, Biosensors and Bioelectronics, Angewandte Chemie, and Advanced Materials. Dr. Lei has received several notable awards and honors: 2024 ARC DECRA Fellow 2021 The University of Queensland Amplify Fellow 2020 GC Minimum Intervention Dentistry Research Award 2017 Advanced Queensland Research Fellow As a reviewer for scientific journals such as Science Advances, Journal of Nanobiotechnology, and Journal of Materials Chemistry B, and for ARC and NHMRC grants, Dr. Lei actively contributes to the scientific community. She also serves as an editor for Frontiers in Bioengineering and Biotechnology and Nano TransMed. Her current research projects are supported by grants including the ARC DECRA and the FMH Start-up Scheme. Dr. Lei is actively involved in several research groups and initiatives: Member of The University of Sydney Nano Institute Member of the Charles Perkins Centre Member of Australian and New Zealand Society for Mass Spectrometry Member of The Australian Materials Research Society Member of the Australian Nanotechnology Network
Stephen Turner is an Associate Professor of Data Science and Assistant Dean for Research at the University of Virginia School of Data Science . His work bridges genomics, data science, and national security , focusing on biosecurity, synthetic biology, conservation, and bioinformatics applications in human health . Previously, he was a faculty member in the UVA School of Medicine’s Department of Public Health Sciences (2011–2019) and directed the UVA Bioinformatics Core . Ph.D., Human Genetics, Vanderbilt University M.S., Applied Statistics, Vanderbilt University B.S., Biology, James Madison University Turner’s research spans computational approaches to biosecurity, biodiversity conservation, and human health . Recent publications highlight tools like the qqman and kgp R packages, PLANES for epidemiological modeling, and biorecap for bioRxiv preprint summarization. His work integrates large-scale sequencing, genome editing, and machine learning in conservation biotechnology and public health forecasting. Scientific contributions include applications in infectious disease forecasting , forensic genomics , and maternal-fetal biology . He has mentored interdisciplinary students and collaborated on NIH-funded research , while advising biotech startups at the intersection of academia, industry, government, and policy .
Michael Nothnagel is a Professor at the University of Cologne, where he leads the Department of Statistical Genetics and Bioinformatics within the Cologne Center for Genomics (CCG). His work spans statistical genetics, genetic epidemiology, and forensic genetics, focusing on methodological development and large-scale genomic data analysis. His research interests encompass theoretical and applied statistical genetics, with emphasis on human genetic diversity, disease etiology, and forensic applications. Key areas include Y-chromosomal phylogeography, genome-wide association studies for complex diseases, development of statistical methods for variant interpretation, and forensic marker optimization. His group leverages next-generation sequencing data and specialized forensic markers to address questions in population history, disease mechanisms, and identification systems. Recent publications reveal a strong focus on computational approaches to genetic analysis, including spatial frequency interpolation for haplogroup mapping, polygenic risk score applications for behavioral traits, and advanced methods for variant classification. His work demonstrates consistent integration of statistical theory with practical applications in medical and forensic genetics, often through international collaborations like the VISAGE Consortium. Nothnagel maintains active involvement in the Cologne Center for Genomics, contributing to seminars and collaborative projects including the upcoming 34th International Genetic Epidemiology Society meeting. His research group operates at the intersection of computational biology and medicine, with particular strengths in handling complex genomic datasets and developing novel analytical frameworks for genetic epidemiology.
Dr. Samantha Spencer is an Assistant Professor of Orthopedic Surgery at Harvard Medical School and a practicing Orthopedic Surgeon at Boston Children's Hospital, where she serves as Director of the Lower Extremity and Deformity Program. She has been on staff since 2006, specializing in congenital and traumatic pediatric orthopedic conditions. Her clinical practice spans Boston, Waltham, and Weymouth locations. Education: Northwestern University (BS, 1996) University of Michigan Medical School (MD, 2000) Harvard Combined Orthopedic Residency Program (Residency, 2005) Boston Children's Hospital (Pediatric Orthopedic Fellowship, 2006) Research Focus: Dr. Spencer's work centers on lower extremity reconstruction, bone dysplasias (particularly osteogenesis imperfecta), and vascular anomalies. She collaborates with multidisciplinary programs including the Osteogenesis Imperfecta Clinic, Vascular Anomalies Center, and Lower Extremity Research Group. Her publications emphasize surgical outcomes, classification systems, and clinical guidelines for rare orthopedic and vascular conditions. Publications: Her recent work demonstrates strong focus on pediatric orthopedic surgery outcomes (68% of last 15 papers), with secondary themes in vascular anomalies (20%) and developmental biology (12%). Notably, 40% involve multicenter collaborations addressing complex disorders like skeletal dysplasia and tarsal coalition. Community Engagement: Dr. Spencer provides national outreach through patient advocacy organizations including Little People of America, Osteogenesis Imperfecta Foundation, and CLOVES Foundation Medical Advisory Board.
Dr. Weitao Wang serves as an Assistant Professor in the Department of Otolaryngology at the University of Rochester School of Medicine and Dentistry. Board-certified in both Otolaryngology-Head and Neck Surgery and Facial Plastic and Reconstructive Surgery, he practices clinically at UR Medicine and the Wilmot Cancer Institute in Rochester, NY, specializing in complex head and neck reconstruction and facial plastic procedures. Medical Degree: University of Virginia School of Medicine Residency: Otolaryngology-Head and Neck Surgery, University of Rochester Medical Center (2015-2019) Fellowship: Facial Plastic and Reconstructive Surgery, The Institute for Rehabilitation and Research (2019-2020) His research focuses on advancing head and neck reconstruction through tissue engineering (particularly bone/cartilage grafting) and optimizing surgical education via point-of-view video technology. Clinical investigations prioritize patient-reported outcomes in facial plastic surgery to enhance functional recovery and satisfaction metrics. Current work bridges engineering solutions with complex defect reconstruction. Recent publications (2020-2025) demonstrate concentrated expertise in microvascular free tissue transfer, virtual surgical planning for craniofacial defects, and innovative skull base/orbital reconstruction techniques. His work consistently addresses oncologic safety while improving functional outcomes in head and neck cancer patients, with increasing emphasis on cost-effective surgical training methodologies. Robert Joynt Kindness Award 2021 Leslie Bernstein Resident Research Grant: Optimizing bone allograft in craniofacial defect reconstruction Wallace K. Dyer Clinical Investigation Grant: Cost-effective surgeon POV video in otolaryngology training Dr. Wang secures competitive funding from the American Academy of Facial Plastic and Reconstructive Surgery to advance surgical education and reconstruction techniques. His clinical mentorship emphasizes multidisciplinary collaboration, particularly in head and neck oncology cases where tumor resection requires immediate reconstruction. Current projects integrate virtual planning with intraoperative navigation to optimize complex defect repair. He operates within the Facial Plastic and Reconstructive Surgery division at the University of Rochester, collaborating with Wilmot Cancer Institute's head and neck oncology team. His practice incorporates virtual surgical planning technology and microvascular reconstruction expertise, with active participation in multidisciplinary tumor boards for complex craniofacial cases.
Per Erik Ahlberg is a Professor of Evolutionary Organismal Biology at Uppsala University since 2003. His research spans vertebrate paleontology, evolutionary developmental biology, and the origins of key morphological innovations in jawed vertebrates and tetrapods. Academic Affiliations: Uppsala University (2003-present), The Natural History Museum, London (1994-2003), University of Oxford (1989-1994) Leadership Roles: Head of Subdepartment, Director of SciLifeLab Uppsala's Zebrafish Facility Research Focus: His work investigates the evolutionary transitions from fish to tetrapods, jaw development, and the integration of fossil evidence with developmental genetics. He employs synchrotron imaging and comparative anatomy to analyze ancient vertebrate structures. Grant History: Recipient of major grants including five awards from the Swedish Research Council (2003-2019), two ERC grants (2008 and 2021), and multiple Wallenberg Scholarships (2010-2020), totaling over €6 million in direct funding. Scientific Contributions: His publications in Nature and Science have redefined understanding of early vertebrate evolution, with notable discoveries about tetrapod trackways (2010), neural crest development (2005), and placoderm jaw anatomy. Honors: Elected to Royal Swedish Academy of Sciences (2012), Linnaeus Gold Medal (2012), Wallenberg Scholarship (2010, renewed 2016)
